184 related articles for article (PubMed ID: 29241656)
1. Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation.
Di Cesare Mannelli L; Tenci B; Micheli L; Vona A; Corti F; Zanardelli M; Lapucci A; Clemente AM; Failli P; Ghelardini C
Neuropharmacology; 2018 Mar; 131():166-175. PubMed ID: 29241656
[TBL] [Abstract][Full Text] [Related]
2. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
[TBL] [Abstract][Full Text] [Related]
3. Glial role in oxaliplatin-induced neuropathic pain.
Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C
Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684
[TBL] [Abstract][Full Text] [Related]
4. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
[TBL] [Abstract][Full Text] [Related]
5. VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.
Micheli L; Parisio C; Lucarini E; Vona A; Toti A; Pacini A; Mello T; Boccella S; Ricciardi F; Maione S; Graziani G; Lacal PM; Failli P; Ghelardini C; Di Cesare Mannelli L
J Exp Clin Cancer Res; 2021 Oct; 40(1):320. PubMed ID: 34649573
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
7. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam.
Di Cesare Mannelli L; Maresca M; Farina C; Scherz MW; Ghelardini C
Neurotoxicology; 2015 Sep; 50():101-7. PubMed ID: 26254739
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.
Sakurai M; Egashira N; Kawashiri T; Yano T; Ikesue H; Oishi R
Pain; 2009 Dec; 147(1-3):165-74. PubMed ID: 19782472
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
Di Cesare Mannelli L; Marcoli M; Micheli L; Zanardelli M; Maura G; Ghelardini C; Cervetto C
Neuropharmacology; 2015 Oct; 97():133-41. PubMed ID: 26071109
[TBL] [Abstract][Full Text] [Related]
10. Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.
Ferrari LF; Chum A; Bogen O; Reichling DB; Levine JD
J Neurosci; 2011 Aug; 31(31):11404-10. PubMed ID: 21813700
[TBL] [Abstract][Full Text] [Related]
11. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain.
Di Cesare Mannelli L; Pacini A; Bonaccini L; Zanardelli M; Mello T; Ghelardini C
J Pain; 2013 Dec; 14(12):1585-600. PubMed ID: 24135431
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.
Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK
Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933
[TBL] [Abstract][Full Text] [Related]
13. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.
Di Cesare Mannelli L; Pacini A; Matera C; Zanardelli M; Mello T; De Amici M; Dallanoce C; Ghelardini C
Neuropharmacology; 2014 Apr; 79():37-48. PubMed ID: 24225197
[TBL] [Abstract][Full Text] [Related]
14. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
[TBL] [Abstract][Full Text] [Related]
15. Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.
Hama A; Natsume T; Ogawa S; Higo N; Hayashi I; Takamatsu H
Pain Res Manag; 2018; 2018():1630709. PubMed ID: 29854035
[TBL] [Abstract][Full Text] [Related]
16. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
17. A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
Di Cesare Mannelli L; Maresca M; Micheli L; Farina C; Scherz MW; Ghelardini C
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1091-1103. PubMed ID: 29026967
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.
Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
J Pain; 2012 Mar; 13(3):276-84. PubMed ID: 22325298
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Oxaliplatin Contributes to the Acute Pain Induced by Systemic Administration of Oxaliplatin.
Huang ZZ; Li D; Ou-Yang HD; Liu CC; Liu XG; Ma C; Wei JY; Liu Y; Xin WJ
Anesthesiology; 2016 May; 124(5):1109-21. PubMed ID: 26978408
[TBL] [Abstract][Full Text] [Related]
20. A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats.
Ferrier J; Bayet-Robert M; Pereira B; Daulhac L; Eschalier A; Pezet D; Moulinoux JP; Balayssac D
PLoS One; 2013; 8(10):e77828. PubMed ID: 24204988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
